LaNeo MDMA 40mg

LaNeo MDMA 40mg

Featured Products

Information

PharmAla's lead product is a scalable 40mg dosage of Methylenedioxymethamphetamine, formulated for use by psychiatrists and psychotherapists in the treatment of Post-Traumatic Stress Disorder. It is under investigation by over 25 different clinical trials at institutions such as Johns Hopkins, UCLA, Yale and many others. Institutional clients include the US Military through the Defence Health Agency, and the US Department of Veterans Affairs.
PharmAla Biotech Holdings Inc.H3.M30PharmAla Biotech is a Canadian biotechnology company specializing in the research, development, and manufacturing of clinical-grade MDMA and novel MDXX compounds. PharmAla operates two primary businesses: the manufacturing of MDMA for the treatment of PTSD, and the research and development of novel MDMA Analogs (MDXX drugs) for the treatment of a diverse array of psychiatric and central nervous system disorders. PharmAla is the global leader in MDMA manufacturing, with clients like the US Veterans Affairs Administration, the US Military, and a broad array of university clients (Yale, Johns Hopkins, Harvard, UCLA, and many others). PharmAla is publicly traded, and was the fastest-growing public stock in Canada in 2023.

Join the event!

See all the content and easy-to-use features by logging in or registering!